Oracle Corp. (ORCL) delivered mixed results in Q4 FY2026 on revenue of $19.2B versus the $19.1B estimate (+20.6% YoY) and EPS of $2.11. The next Oracle Corp. (ORCL) earnings date is Sep 8, 2026. Below is the full Oracle Corp. earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Oracle Corp. (ORCL) Earnings Analysis — key stats
Next earnings date
Sep 8, 2026
Latest reported quarter
Q4 FY2026
Earnings verdict
Mixed
EPS beat rate
5 of last 8 (quarters above estimate)
Avg next-day move
±12.9% (over the last 8 reports)
Post-earnings direction
Up 4 / Down 4 (of the last 8 reports)
Implied move (next report)
±23.9% (options-derived · into Sep 8, 2026)
Revenue
$19.2B (vs $19.1B est · +0.4% surprise · +20.6% YoY)
EPS
$2.11 (vs $1.96 est · +7.7% surprise · +20.5% YoY)
Share price
$140.27 (-1.6%)
Market cap
$404.0B
Oracle Corp. (ORCL) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q2 2026
$19.2B vs $19.1B est
$2.11 vs $1.96 est
+7.7%
-10.5%
Mixed
Q1 2026
$17.2B vs $16.9B est
$1.79 vs $1.70 est
+5.3%
+7.6%
Mixed
Q4 2025
$16.1B vs $16.2B est
$2.26 vs $1.64 est
+37.8%
-10.2%
Mixed
Q3 2025
$14.9B vs $15.0B est
$1.47 vs $1.48 est
-0.7%
+37.7%
In line
Q2 2025
$15.9B vs $15.6B est
$1.70 vs $1.64 est
+3.7%
+12.6%
Beat
Q1 2025
$14.1B vs $14.4B est
$1.47 vs $1.49 est
-1.3%
-7.1%
In line
Q4 2024
$14.1B vs $14.1B est
$1.47 vs $1.48 est
-0.7%
-7.3%
In line
Q3 2024
$13.3B vs $13.2B est
$1.39 vs $1.33 est
+4.5%
+9.9%
Mixed
What you'll find
Next Oracle Corp. (ORCL) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Oracle Corp. reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Oracle Corp. (ORCL)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Oracle Corp.'s next earnings date?
Oracle Corp.'s (ORCL) next scheduled earnings date is Sep 8, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Oracle Corp. (ORCL) beat or miss earnings?
In Q4 FY2026, Oracle Corp. (ORCL) posted mixed results — revenue of $19.2B versus the $19.1B estimate (+0.4% surprise) and EPS of $2.11 versus $1.96 expected (+7.7% surprise). Magnisto decodes every Oracle Corp. (ORCL) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Oracle Corp. beat earnings estimates?
Over its last 8 reported quarters, Oracle Corp. (ORCL) beat Wall Street EPS estimates 5 times, most recently a mixed result in Q2 2026. Magnisto tracks every Oracle Corp. (ORCL) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Oracle Corp. stock move after earnings?
Over its last 8 quarterly reports, Oracle Corp. (ORCL) moved an average of ±12.9% the day after earnings — ranging from -10.5% (Q2 2026) to +37.7% (Q3 2025). The stock rose after 4 of those 8 reports and fell after 4. Heading into its next report on Sep 8, 2026, options-implied volatility is pricing in a move of roughly ±23.9% (derived). Magnisto tracks the realized post-earnings move for every Oracle Corp. (ORCL) quarter alongside the beat/miss verdict — past moves don't predict the next one.
What is the forecast for Oracle Corp. (ORCL) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Oracle Corp. (ORCL), anchored to the current $140.27 share price, so you can weigh the bull, base and bear cases for Oracle Corp. side by side.
Is Oracle Corp. (ORCL) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Oracle Corp. fits your own thesis and risk profile. This is research, not investment advice.